Recombinant human protein reagents that behave the same next time

Specifying and qualifying a lot

1. Choose the host for the modification you need. Bacterial expression gives unmodified protein cheaply; mammalian and insect systems give glycosylation that may be essential for activity or binding. The host is part of the reagent identity.
2. Demand specific activity, not just purity. Purity says what fraction is your protein; specific activity says how much of it works. A lot can be pure and largely misfolded, and only the activity figure reveals it.
3. Check endotoxin and aggregate content. Endotoxin provokes responses easily mistaken for the protein's effect, and aggregates change potency and can be immunogenic. Both belong on the certificate.
4. Know whether carrier protein is present. Carrier stabilises dilute preparations and interferes with some assays and with conjugation. A carrier free version exists for those cases and is a different product.
5. Titrate every new lot. Match lots by activity in your own assay rather than by stated mass. It is one dose response and it prevents a step change in the middle of a study.
6. Measure heterogeneity where it matters. For proteins whose charge or glycan distribution affects function, a charge variant separation describes the lot in a way a purity figure cannot.

Activity is the specification

Mass is easy to measure and easy to quote, and it predicts biological effect poorly. Specific activity in a defined assay is what actually transfers between lots and between laboratories.

Where a supplier will not state it, treat the reagent as uncharacterised for quantitative work and titrate every lot yourself.

Record the lot with the experiment

For this class of reagent the lot is the most likely explanation of an unexpected result, and it is the field most often missing from a methods section.

Recording supplier, catalogue number and lot costs nothing and turns an argument into a lookup.

Buy recombinant protein, or express it yourself

Buying a recombinant protein is the right answer whenever the protein is a reagent rather than the experiment: a catalogue item comes with a lot number, an activity assay and a purity figure, and it arrives this week. Expressing it yourself pays when you need a variant nobody sells, a tag or label that changes the construct, quantities in the tens of milligrams, or control over the expression host because glycosylation matters. Compare the catalogue price per microgram of active protein against a realistic internal cost, which includes the construct, the small scale trial and the purification, not just the media.

protein purification his tag work, and its buffer constraints

Immobilised metal affinity chromatography puts real limits on the buffers around it. Chelators are out, so no EDTA in the lysis buffer; strong reducing agents strip nickel, so DTT is replaced with a low concentration of TCEP or beta-mercaptoethanol; phosphate is tolerated but high imidazole in the load is not, although a low concentration suppresses weak binders and improves purity. Salt is usually raised to reduce non-specific binding. Plan the whole train around those constraints rather than adding a buffer exchange to rescue a lysate that was never compatible.

protein hplc, and the modes a protein tolerates

Running a protein on an HPLC is a different exercise from a small molecule. Size exclusion reports aggregation and is the workhorse; ion exchange resolves charge variants; hydrophobic interaction separates conformers and conjugates; reversed phase resolves best and costs activity, since the organic solvent and the acid usually denature what they separate. Wide pore packings exist because a protein has to reach the surface. Choose the mode by the attribute you are measuring, and accept that a denaturing method measures identity rather than function.

gst tagged protein purification, and gst protein purification without a tag

gst tagged protein purification uses a glutathione resin to capture the fusion, elutes with free glutathione and then removes the tag with a specific protease, which is why the linker design decides whether cleavage works. gst protein purification of the enzyme itself is a different job with the same resin. The tag dimerises, so an oligomeric state measured before cleavage is the tag's and not the protein's.

Common questions

Why does a new lot behave differently?

Specific activity differs between lots because folding, aggregation and modification differ. Matching by stated mass rather than by activity is the usual cause of a step change mid study.

Does the expression host matter for a recombinant human protein if the sequence is the same?

Frequently yes. Glycosylation and disulphide formation differ between hosts and can change activity, stability and binding, so the host is part of the reagent specification.

Carrier free or with carrier?

Carrier stabilises dilute stocks and interferes with conjugation and with some assays. Choose deliberately and keep it consistent, because switching changes effective concentration.

Browse by service class

• Compare Gene synthesis on advertised prices